Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 021130

Expand all

ZYVOX (LINEZOLID)
600MG Marketing Status: Prescription

Active Ingredient: LINEZOLID
Proprietary Name: ZYVOX
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 600MG
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: AB
Application Number: N021130
Product Number: 002
Approval Date: Apr 18, 2000
Applicant Holder Full Name: PHARMACIA AND UPJOHN CO
Marketing Status:  Prescription
Patent and Exclusivity Information

ZYVOX (LINEZOLID)
400MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** Marketing Status: Discontinued

Active Ingredient: LINEZOLID
Proprietary Name: ZYVOX
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 400MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Reference Listed Drug: Yes
Reference Standard: No
TE Code: 
Application Number: N021130
Product Number: 001
Approval Date: Apr 18, 2000
Applicant Holder Full Name: PHARMACIA AND UPJOHN CO
Marketing Status:  Discontinued
Patent and Exclusivity Information

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English